Regorafenib
Regorafenib is a multi-target inhibitor for VEGFR1, VEGFR2, VEGFR3, PDGFRβ, Kit (c-Kit), RET (c-RET) and Raf-1 with IC50 of 13 nM/4.2 nM/46 nM, 22 nM, 7 nM, 1.5 nM and 2.5 nM in cell-free assays, respectively. Regorafenib induces autophagy.
Supplier | Selleck Chemicals |
---|---|
Product # | S1178 |
Sku # | S1178-100mg |
Pricing | 100mg, $589.00 |
Citations for this product:
-
bioRxiv - Cancer Biology 2022Quote: ... Cells were treated with 4 μM regorafenib (Selleck Chemicals Cat# S1178), alone or in combination with 1 mM aspirin (Selleck Chemicals Cat# S3017) ...